Clinical Trials
3 trialsNCT01147393 2018-02-22
Combination Veltuzumab and Fractionated 90Y- Epratuzumab Radioimmunotherapy in Follicular Lymphoma
Weill Medical College of Cornell University
Phase 1/2 Terminated
NCT00989586 2017-02-06
Veltuzumab and Milatuzumab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
Ohio State University Comprehensive Cancer Center
Phase 1/2 Completed
NCT01279707 2014-07-14
MARALL
Queen Mary University of London
Phase 1/2 Unknown